The expression of two immunosuppressive SIGLEC family molecules in papillary thyroid cancer and their effect on prognosis.

Tiefeng Jin,Wei Wang,Luqi Ge,Xiang Li,Minghua Ge

Endocrine（2023）

引用 0|浏览4

暂无评分

摘要

Therefore, our results indicate that SIGLEC10 and SIGLEC15 may be applied as significant prognostic markers for PTC and attractive targets for THCA immunotherapy.

查看译文

关键词

Papillary thyroid cancer, Immune checkpoint, SIGLEC10, SIGLEC15, Immunotherapy, Prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要